Back
The New York Times Co. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
86
NYT
The New York Times Co.
Last Price:
$70.79
Seasonality Move:
5.79%
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.73
Seasonality Move:
11.35%
Buy
86
The New York Times Co. (NYT)
is a Buy
Is The New York Times Co. a Buy, Sell or Hold?
-
The current The New York Times Co. [NYT] share price is $70.79. The Score for NYT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NYT Stock Price Chart
What is The New York Times Co.'s stock price today?
-
The The New York Times Co. share price today is $70.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NYT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.19 | Buy |
| Relative Strength Index (14 RSI): | 81.3 | Buy |
| Chaikin Money Flow: | -68133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.45 - 67.91) | Buy |
| Bollinger Bands (100): | (55.74 - 63.94) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.77 | Buy |
| Relative Strength Index (14 RSI): | 85.1 | Buy |
| Chaikin Money Flow: | 991653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.01 - 220.61) | Buy |
| Bollinger Bands (100): | (55.63 - 178.69) | Buy |
NYT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.65 | Buy |
| 20-day SMA: | 66.2 | Buy |
| 50-day SMA: | 61.77 | Buy |
| 200-day SMA: | 56.22 | Buy |
| 8-day EMA: | 68.7 | Buy |
| 20-day EMA: | 66.52 | Buy |
| 50-day EMA: | 63.24 | Buy |
| 200-day EMA: | 57.7 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.26 | Buy |
| 20-day SMA: | 220.14 | Buy |
| 50-day SMA: | 161.87 | Buy |
| 200-day SMA: | 73.76 | Buy |
| 8-day EMA: | 220.14 | Buy |
| 20-day EMA: | 210.53 | Buy |
| 50-day EMA: | 173.33 | Buy |
| 200-day EMA: | 94.53 | Buy |
The New York Times Co. Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
The New York Times Co. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||